Mevion Medical Systems
300 Foster Street
45 articles with Mevion Medical Systems
Mevion to Highlight Expanded Image-Guided Proton Therapy and Patient Positioning Offerings at ASTRO 2019
Dr. Carlos Perez joins Mevion’s Advisory Committee
Mevion Medical Systems is pleased to announce its strategic partner, medPhoton GmbH, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ceiling-mounted ImagingRing™, an innovative in-room cone-beam computed tomography (CBCT) imaging system.
The union of both products supports a seamless workflow with uninterrupted patient surface tracking and monitoring from setup through treatment.
Qfix and Mevion Medical Systems are pleased to announce that a special version of the kVue™ One Proton couch top is now both validated and available on MEVION S250™ Series Proton Therapy Systems.
When combined with Mevion Proton Therapy Systems, the kVue One and the expansive array of kVue inserts provide clinicians the flexibility to develop and manage treatments that are best suited for each patient's specific needs.
Accelerator for 2nd Mevion Proton Therapy System Delivered to Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis MO
Mevion Medical Systems has delivered the accelerator for a second Mevion proton therapy system to the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri.
RaySearch and Mevion Extend Collaboration to Support Advanced HYPERSCAN Treatment Planning Capabilities
Two of the leaders in the field of proton therapy, Mevion Medical Systems and RaySearch Laboratories AB (publ), have collaborated since 2014.
Mevion and RaySearch Extend Collaboration to Support Advanced HYPERSCAN Treatment Planning Capabilities
Two of the leaders in the field of proton therapy, Mevion Medical Systems and RaySearch Laboratories AB (publ), have collaborated since 2014. The companies are now strengthening their strategic collaboration effort to further advance capabilities with Mevion’s HYPERSCAN® proton therapy system and the unique Adaptive Aperture® proton multi-leaf collimator (pMLC) in the treatment planning system RayStation®.
Mevion Medical Systems announced the sales of two HYPERSCAN® Pencil Beam Scanning upgrades to American Shared Hospital Services.
This will be the first MEVION S250i Proton Therapy System in the Asia-Pacific Region.
Mevion Medical Systems announced today that Chief Executive Officer, Tina Yu, Ph.D., will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 09, 2019 at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco, California.
Huntsman Cancer Institute at the University of Utah Selects Mevion to Provide Compact Single-Room System for the First Proton Therapy Center in Utah
The National Cancer Institute-designated Comprehensive Cancer Center will be the first hospital to offer proton therapy in the Mountain West.
Mevion Medical Systems Successfully Completes Growth Financing; Well Positioned for Global Expansion
Mevion Medical Systems, Inc. announced the successful closing of a $150 million financing transaction led by YuanMing Capital and other private equity investors
MedStar Georgetown University Hospital Begins Treatments with the HYPERSCAN™ Pencil Beam Scanning System
HYPERSCAN PBS introduces novel energy layer switching and automated collimation systems.
CE Marking permits clinical use of the system within the European Union and any country that recognizes the CE Mark. The MEVION S250i system includes HYPERSCAN™ technology, the next generation of pencil beam scanning (PBS) for faster, sharper, and more robust proton treatments.
Mevion Medical Systems Submits 510(K) Premarket Notification For The MEVION S250i Proton Therapy System With HYPERSCAN Technology
Mevion Medical Systems Release: Mevion Single Room Proton Therapy System Treats More Than 520 Patients In Two Years
Mevion Medical Systems Installs Breakthrough Proton Pencil Beam Scanning Technology At Medstar Georgetown University Hospital